Page last updated: 2024-11-04

linsidomine and Helicobacter Infections

linsidomine has been researched along with Helicobacter Infections in 2 studies

linsidomine: RN given refers to parent cpd; structure

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, JW1
Kim, H1
Kim, KH1
Hiraishi, H1
Oinuma, T1
Sasai, T1
Yoshiura, K1
Shimada, T1
Terano, A1

Reviews

1 review available for linsidomine and Helicobacter Infections

ArticleYear
[Mechanism of gastric mucosal cell injury induced by reactive oxygen species and nitric oxide].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2

    Topics: Animals; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Molsidomin

2002

Other Studies

1 other study available for linsidomine and Helicobacter Infections

ArticleYear
NF-kappaB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection.
    Free radical biology & medicine, 2001, Aug-01, Volume: 31, Issue:3

    Topics: Antioxidants; Apoptosis; Catalase; Cell Line; Cell Survival; Enzyme Induction; Gastric Mucosa; Gene

2001